Projects

Since three years, the Single Cell Manipulator (SCM) Technology which has been developed at IMTEK is in use at various European partners from the fields of cancer research, production of clonal cell lines, and automated patch clamping. Due to this success, its’ broad range of suitable applications, and the high maturity level meanwhile achieved, a BMWi funding in the framework of “EXIST Forschungstransfer” was granted. Within this project termed “Single Cells on Demand” (SCoD) the existing SCM Technology will be further developed towards market maturity, and customer acquisition, marketing, and distribution will be pushed with the goal to spin-off a company from university. For the founder team around the two PhD students Jonas Schöndube and Andre Gross, besides the research and engineering work to be done, intense coaching and the participation on business plan competitions are also on the schedule. The product to be developed for the spin-off company would first be available on the life-science market. Primarily it should help researchers to open new ways in single cell analysis and support pharmaceutical companies in developing new, improved agents. Main application fields are cancer research and diagnostics, drug discovery, and personalized medicine. Due to the SCM Technologies’ high flexibility and universal applicability ever more application fields will be become accessible in near future.